In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

被引：124

作者：

Van Herrewege, Y

Michiels, J

Van Roey, J

Fransen, K

Kestens, L

Balzarini, J

Lewi, P

Vanham, G

Janssen, P

机构：

[1] Inst Trop Med, Dept Microbiol, Immunol Lab, B-2000 Antwerp, Belgium

[2] Inst Trop Med, Dept Microbiol, AIDS Reference Lab, B-2000 Antwerp, Belgium

[3] Tibotec Virco NV, Mechelen, Belgium

[4] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Louvain, Belgium

[5] Janssen Pharmaceut, Ctr Mol Design, Vosselaar, Belgium

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 01期

关键词：

D O I：

10.1128/AAC.48.1.337-339.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 (Dapivirine) effectively prevented human immunodeficiency virus (HIV) infection in cocultures of monocyte-derived dendritic cells and T cells, representing primary targets in sexual transmission. Both drugs had a favorable therapeutic index. A 24-h treatment with 1,000 nM UC-781 or 100 nM TMC120-R147681 prevented cell-free HIV infection, whereas 10-fold-higher concentrations blocked cell-associated HIV.

引用

页码：337 / 339

页数：3